根據最新的財務報表(Form-10K),KORU Medical Systems Inc 的總資產為 $28,淨損失為 $-2
KRMD 的關鍵財務比率是什麼?
KORU Medical Systems Inc 的流動比率為 2.54,淨利潤率為 -4.87,每股銷售為 $0.88。
KORU Medical Systems Inc 的收入按細分市場或地理位置如何劃分?
KORU Medical Systems Inc 最大收入來源為 Domestic Core,在最近的收益報告中收入為 25,214,613。就地區而言,United States 是 KORU Medical Systems Inc 的主要市場,收入為 27,506,682。
KORU Medical Systems Inc 是否盈利?
無,根據最新的財務報表,KORU Medical Systems Inc 的淨損失為 $-2
KORU Medical Systems Inc 有負債嗎?
是的,KORU Medical Systems Inc 的負債為 11
KORU Medical Systems Inc 的流通股有多少?
KORU Medical Systems Inc 的總流通股為 46.37
關鍵數據
前收市價
$4.43
開盤價
$4.41
當日範圍
$4.32 - $4.44
52週區間
$1.86 - $6.6
交易量
122.7K
平均成交量
196.1K
股息收益率
--
每股盈餘 (TTM)
-0.08
市值
$203.8M
什麼是 KRMD?
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 80 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.